MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹5.92 Cr | ₹4.56 Cr | ₹3.25 Cr | ₹1.86 Cr | ₹2.11 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹5.92 Cr |
Mar2024 | ₹4.56 Cr |
Mar2023 | ₹3.25 Cr |
Mar2022 | ₹1.86 Cr |
Mar2021 | ₹2.11 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹5.92 Cr | 29.85 | |
Mar2024 | ₹4.56 Cr | 40.19 | |
Mar2023 | ₹3.25 Cr | 75.22 | |
Mar2022 | ₹1.86 Cr | -12.08 | |
Mar2021 | ₹2.11 Cr | - |
Compare Long Term Provisions of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹8,119.1 Cr | 2.8% | -1.3% | -39.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 2.8% |
-1.3% |
-39.8% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses